Cannabis-Startups.com

We've just released the latest episode of Financing Your Cannabis Future with Rachel Wright, CPA, MST, founder of VERDANT Strategies—where she speaks with Falk Altenhoefer about the developments of the German cannabis market. Catch the full episode over on our YouTube channel. https://lnkd.in/gNYbjnUS Please don't forget to LIKE and SUBSCRIBE!

🚀 Major milestone for European startups! 🇪🇺 The European Commission has officially launched a high-level task force dedicated to solving challenges faced by startups. What’s groundbreaking? This initiative operates directly under Ursula von der Leyen, marking the first time startups have received attention at such a high political level. Their flagship mission? The creation of a pan-European legal entity—dubbed EU-Inc or the 28th regime. 🌍 This could revolutionize scaling across borders, simplifying operations for startups across Europe. Brussels is stepping up for startups. Let’s hope this ambition turns into real action and fuels innovation across the continent! 🔥 💡 Exciting times ahead for cannabis startups, too—time to seize the opportunity!

Wie finanzieren sich Cannabis-Unternehmen in Europa, wie in den USA? Was sind die Unterschiede? Welche Rolle spielen Kredite, welche Rolle Investoren? Ein Feature von Falk Altenhöfer: https://lnkd.in/d7wdfyRy

🌿 Cannabis Legalization and the Role of Pharmacies: Challenges and Opportunities 🌿 With the legalization of recreational cannabis and the growing demand for medical cannabis, pharmacies in Germany are facing challenges again. Compounded cannabis medications are vital for treating chronic pain and severe conditions, but economic pressures like retaxation are creating significant challenges. How can pharmacies adapt to these changes? Specialization, expertise, and volume effects are emerging as key success factors. Those who embrace cannabis as a core business have the potential to thrive, while others risk being left behind. In my latest article, I explore: ✅ The economic impact of retaxation on cannabis prescriptions ✅ Why specialization is crucial for pharmacies ✅ The future of the cannabis prescription market Let’s discuss how pharmacies can navigate this evolving landscape and ensure quality patient care remains a priority. 👉 Read the full article here: https://lnkd.in/eSZ5tYE2

The 2024 ICBC Rap in Review! Ngaio Bealum, Jamie L. Pearson, Yoko Miyashita, Peter Homberg, Claudia Della Mora, Kai-Friedrich Niermann, Benedikt Sons, Philipp Goebel, Thomas Schatton, Ricardo Geada, Sita Schubert, Alex Revich, Margret Knitter, LL.M. (Edinburgh), Stefan Röhrl, Spiros Malandrakis, Andrew Freedman, Beau Whitney, Yoram Eshel, Michael Knodt, Markus Roggen, Tamara Lah Turnšek, Markus Veit, Dwayne Stewart, Barinder S. Bhullar, Justin Tombe, Francesco B., Christian Ulrichs, Bozidar Radisic, Daniel Haymann, Gašper Friškovec, Lisa Haag, Atiyyah Ferouz, Frederik Bockslaff, Giadha Aguirre de Carcer, Will Muecke, Benjamin Kraim, Deepak Anand, Jürgen Bickel, Marco Cadisch, Andy Mannsfeld, M.D.

THIS IS YOUR 2025 ENERGY

What a Year for Cannabis Startups in Germany! 🚀 Looking back, it’s incredible to see how far the cannabis industry has come in just one year—and how much effort it took to navigate the complexities of launching in this space. At the start of 2024, we were meticulously strategizing to ensure compliance with marketing regulations. Operating in a still-grey legal area felt like walking a tightrope, with every move needing to be carefully calculated. One vivid memory is working with Lothar Wagner in a private “grow environment,” a space where many growers still kept their operations hidden. Fast forward to today: cannabis startups are stepping into the spotlight, making waves at events like the GIF—now TALMAN HOUSE—where innovation and progress are proudly on display. (Have a look at the picture!) This year has been nothing short of transformative. Germany has become the focal point of the European cannabis industry, attracting global attention. Companies everywhere are exploring strategies to establish their footprint here, blending “buy or build” approaches to position themselves for long-term success. Read in detail about our year here: https://lnkd.in/eV9muJdW

🌿 Why Extract Suppliers Could Flourish NOW 🌿 📈 Growing Demand for Ready-to-Use Products: Pharmacies are under stricter regulations, making compliance costly and time-consuming. Many are now turning to pre-approved, ready-to-use medicinal products. 🏆 Regulatory Advantage: Licensed manufacturers offering high-quality, finished products are set to dominate. As pharmacies move away from compounding, the demand for pre-packaged solutions is skyrocketing. This shift presents a massive opportunity for extract suppliers to thrive in the evolving medicinal cannabis market. 💡 Check out the infographic below for more insights, sponsored by Elixie Ltd!

🚀 Unlock the Future of Medical Cannabis of Extracts in Germany 🚀 The German medical cannabis market is evolving rapidly, and recent court rulings are reshaping the landscape. From regulatory changes to the growing demand for ready-to-use cannabis extracts, now is the time for suppliers to capitalize on new opportunities. 🔍 What you’ll learn in our latest whitepaper: - Insights into the recent Düsseldorf court ruling on Dronabinol - Pricing trends and market dynamics for cannabis extracts in Germany - Key strategies for extract suppliers to thrive in the evolving market - How to align with Germany's strict regulatory framework 💡 If you’re a cannabis extract supplier or industry professional, this whitepaper is a must-read to stay ahead of the curve. 📥 Download the whitepaper now and get the insights you need to lead the market: https://lnkd.in/e-a8CSkt

8 Months After Cannabis Legalization in Germany: My Take on an article published today! It feels like we're catching up to the U.S. in many ways: - Medical cannabis access has never been easier. You can now order it online, no doctor's visit is required! - Home cultivation is a reality. Growing up to 3 plants per person is allowed (more than enough for most consumers!) - Cannabis clubs are opening. For those who can’t or don’t want to grow at home, non-profit clubs offer a place to connect with like-minded individuals and access cannabis. What This Means: - Online platforms are booming, offering streamlined tracking, ordering, and even hourly delivery of medical Cannabis. - Companies scaling fast—expect to see more investments, IPOs, and acquisitions in the near future. What’s Still Missing: => Product diversity. While extracts are available, we’re still waiting for edibles and other forms of cannabis to hit the market. 👉 Read the summary of the article in English: https://lnkd.in/e5yr36sk (I can't post the article legally because it's behind a paywall!) What’s your take on the industry so far and for next year? Send me a message and I will include it in an article! 🚀